The Anti-Corruption Bureau of the Central Bureau of Investigation has filed corruption charges against two former directors of Regional Institute of Medical Sciences (RIMS), Imphal.
Lallukham Fimate, a former director of RIMS has been charged with buying a cancer detection machine from a foreign company at Rs.2.31 crore, while a similar machine is available for Rs.1 crore in India, the CBI has said.
Sinam Sekharjit, another former director, was charged with buying dental chairs and accessories at inflated rates amd incurring a loss of Rs.50 lakh. His first hearing in the special court in Imphal is fixed for April 21.
Thoudam Tomcha, head of department of the radiotherapy department, is one of the respondents in the case.
Meanwhile, the Kangleipak Communist Party (Military Joint Commitee) has claimed responsibility for the grenade blast at the house of M. Amuba, the medical superintendent of RIMS, on the night of April 10, for his alleged corrupt practices.
Two earlier blasts were claimed by another outfit.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app